Canbro Pharmaceuticals Private Limited, a active private limited company, was established on 07 June 2019 in Karnal, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304HR2019PTC080778. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹7.00 M.
Its leadership includes Manoj Malhotra (Director), Parikshit Malhotra (Director), Dinesh Kumar Singh (Additional Director). Past directors included Rewati Raman Rai, Santkumar, Shambhu Kumar. It holds ₹1.60 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot 374, Sector-3 Extension, Karnal, Haryana, 132001.
U24304HR2019PTC080778
080778
07 June 2019
₹7.00 M
₹7.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Canbro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Malhotra | Director | 07 Jun 2019 | Current |
| Parikshit Malhotra | Director | 07 Jun 2019 | Current |
| Dinesh Kumar Singh | Additional Director | 20 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 19 Jan 2023 | Past |
| Pramod Abcsdd | Director | 30 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 04 Jan 2025 | Past |
| Pramod Abcsdd | Additional Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canbro Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Canbro Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹16,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2019 | Others | ₹1.00 Cr | Open |
| 31 Dec 2019 | Others | ₹6.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Canbro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canbro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canbro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dinesh Kumar Singh was appointed as a Additional Director was appointed as a Additional Director on 20 Mar 2025 & has been associated with this company since 9 months 7 days . was completed.
The activity Canbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Canbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 100312909 was registered on 31 Dec 2019. was completed.
A charge with Others amounted to Rs. 6.00 M with Charge ID 100312461 was registered on 31 Dec 2019. was recorded as a recent event.
Progress on Manoj Malhotra was appointed as a Director was appointed as a Director on 07 Jun 2019 & has been associated with this company since 6 years 6 months . was documented.
The CIN of Canbro Pharmaceuticals Private Limited is U24304HR2019PTC080778.
Canbro Pharmaceuticals Private Limited is headquartered at Plot 374, Sector-3 Extension, Karnal, Haryana, 132001.
Canbro Pharmaceuticals Private Limited was incorporated on 07 June 2019.
The current directors of Canbro Pharmaceuticals Private Limited are
The primary industry of Canbro Pharmaceuticals Private Limited is Manufacturing.
Canbro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Canbro Pharmaceuticals Private Limited is ₹7.00 M, and the paid-up capital is ₹7.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX